The current growing interest for natural antioxidants has led to a renewed scientific attention for artichoke, due not only to its nutritional value, but, overall, to its polyphenolic content, showing strong antioxidant properties. The major constituents of artichoke extracts are hydroxycinnamic acids such as chlorogenic acid, dicaffeoylquinic acids caffeic acid and ferulic acid, and flavonoids such as luteolin and apigenin glycosides. In vitro studies, using cultured rat hepatocytes, have shown its hepatoprotective functions and in vivo studies have shown the inhibition of cholesterol biosynthesis in human subjects. Several studies have shown the effect on animal models of artichoke extracts, while information on human bioavailability and metabolism of hydroxycinnamates derivatives is still lacking. Results showed a plasma maximum concentration of 6·4 (SD 1.8) ng/ml for chlorogenic acid after 1 h and its disappearance within 2 h (P, 0·05). Peak plasma concentrations of 19·5 (SD6·9) ng/ml for total caffeic acid were reached within 1 h, while ferulic acid plasma concentrations showed a biphasic profile with 6·4 (SD1·5) ng/ml and 8·4 (SD4·6) ng/ml within 1 h and after 8 h respectively. We observed a significant increase of dihydrocaffeic acid and dihydroferulic acid total levels after 8 h (P,0·05). No circulating plasma levels of luteolin and apigenin were present. Our study confirms the bioavailability of metabolites of hydroxycinnamic acids after ingestion of cooked edible Cynara scolymus L. (cultivar Violetto di Provenza).
Artichoke (Cynara scolymus L.) is an ancient herbaceous perennial plant, originating from the Mediterranean area, which today is cultivated all over the world. The leaves of artichoke have been widely used in herbal medicine as a choleretic and diuretic since ancient times (Bruneton, 1995) .
Several studies have demonstrated the efficiency and safety of artichoke extracts in the treatment of hepato-biliary disfunction and digestive complaints in animals (Adzet et al. 1987; Speroni et al. 2003) and in human subjects (Kraft, 1997; Kirchhoff et al. 1994) . Several clinical investigations showed the ability of artichoke extract to prevent the oxidative modification of blood lipoproteins and to reduce blood cholesterol levels (Kirchhoff et al. 1994; Gebhardt, 1998 Gebhardt, , 2002 Zapolska-Downar et al. 2002; Shimoda et al. 2003) . Moreover leaf extracts have been reported to show antioxidative and protective properties against hydroperoxide-induced oxidative stress in cultured rat hepatocytes (Gebhardt, 1997; Miccadei et al. 2004) . Artichoke beneficial effects seem due to the biochemical constituents, mainly polyphenols (chlorogenic acid (CGA), mono-and di-caffeoylquinic acids and flavonoids such as luteolin and apigenin glycosides), sugars and inulin. The health-promoting prebiotic effects of artichoke inulin were related to the stimulation of bifidobacterial growth in the intestine (Roberfroid et al. 1998; Lopez-Molina et al. 2005) . The characterization and quantification of bioactive molecules in artichoke have been studied extensively (Wang et al. 2003; Schütz et al. 2004; Zhu et al. 2004) while little is known on the bioavailability and bioactivity of these substance from natural or supplemental sources. Polyphenols are abundant micronutrients in our diet and evidence for their role in the prevention of degenerative disease is emerging. Bioavailability greatly differs from one polyphenol to another, so that the most abundant polyphenols in our diet are not necessarily those leading to the highest concentration of active metabolites on target tissues (Manach et al. 2004 .
The aim of this study was to evaluate the absorption and metabolism of bioactive molecules after oral consumption of cooked edible portion of artichoke heads in human subjects.
Materials and methods

Chemicals and reagents
All solvent reagents were HPLC or Optima grade; common reagents were purchased from Sigma (St Louis, MO, USA), Carlo Erba (Milan, Italy) and BDH Laboratory Supplies. (Poole, Dorset, UK) CGA, caffeic acid (CA), ferulic acid (FA), apigenin (Lyon Nord, France) and luteolin were purchased from Sigma, dihydrocaffeic acid (DHCA) from Extrasynthese (Lyon Nord, France) and dihydroferulic acid (DHFA) from AVO-CADO Research Chemicals Ltd (Morecambe, Lancashire, UK).
Subjects
Five healthy non smoking subjects (two males and three females), aged 25-32 years, body weight 61·0 (SD 9.5) kg and BMI 21·5 (SD 1·5) kg/m 2 , were recruited on the basis of their normal blood values and clinical anamnesis from the National Institute for Research on Food and Nutrition staff (INRAN, Rome).
Each subject signed an informed consent approved by the Ethical Committee of INRAN. Several studies have shown significant effects of treatment with a small number of subjects (Hollman et al. 1996; McAnlis et al. 1999; Cremin et al. 2001; Rechner et al. 2001a; Olthof et al. 2001; Bugianesi et al. 2004 ).
Subjects did not use any drug or vitamin supplementation. During the three days before the experimental day, subjects were asked to follow a controlled diet limiting fruit and vegetables consumption to not more than 100 g/day, and avoiding artichokes, carrots, tomatoes, apples, pears, peaches, cherries, strawberries, blueberries, tea, coffee, wine, beer, chocolate and all their derived products. Food consumption during the three days of wash out was surveyed by a dietitian to check the diet balance by a record and recall method.
Study design
After fasting overnight, baseline blood samples were collected from each subject. After blood collection, all subjects consumed 61·7 (SD 4·4) g edible artichoke (cultivar Violetto di Provenza), steam cooked with 5·5 (SD 0·4) g extra virgin olive oil and venous blood sample collection was repeated at 0·5, 1, 2, 4, 6 and 8 h from the experimental test meal consumption.
Total energy and macronutrient content were calculated by using Food Composition Tables (National Institute for Research on Food and Nutrition, 2000) . CGA, mono-and di-caffeoylquinic acids, cynarin (1,3-dicaffeoylquinic acid), luteolin-glycoside and apigenin-glycoside contents of the experimental meal are reported in Table 1 .
The edible portion of artichoke heads was chosen on the basis of analysed polyphenols content of cultivar selected for the study. Artichoke heads, consumed by all participants, were collected raw and cooked in order to evaluate the polyphenol contents. Table 2 shows replicate analyses of artichoke heads both raw, and cooked as mg/100 g edible portion.
Artichoke analysis
About 25 g raw and cooked heads of artichoke were homogenized in a 250 ml flask by adding 150 ml MeOH and were extracted by stirring, heating and refluxing for 90 min with regular swirling.
The solutions obtained were filtered and the residues were extracted twice after adding 100 ml MeOH by stirring, heating and refluxing for 30 min with regular swirling. Pooled extracts were evaporated by rotavapor and reconstituted by adding 100 ml H 2 O -MeOH (1:1, v/v).
The determination of polyphenols in artichoke heads was carried out in agreement with Di Venere et al. (2005) and the quantification was performed by HPLC using a liquid chromatograph equipped with binary gradient pump and spectrophotometric photodiode array detector (Agilent Technologies S.P.A., Milan, Italy). The Hewlett Packard Chem Station (Rev. A. 06.03) software was used for spectra and data processing. An analytical Phenomenex (Torrance, CA, USA) Ultracarb 5 ODS (30) column (4·6 £ 250 mm) was used for peak separation and the elution profile was reported by Lattanzio & Van Sumere (1987) . The method recovery performance was assayed by addition of suitable amounts of standards prior to the extraction of the solid samples. Recovery rates of the method were found to be .85 % for caffeoylquinic acids as well as luteolin and apigenin glycosides.
The method precision was assayed by three series of extractions, each performed in triplicate using one different artichoke head. The percentage relative standard deviation for the normalized peak areas of all evaluated compounds was found to be , 5 % (data not shown).
Plasma samples
Blood samples were drawn into vacutainers containing EDTA as anticoagulant. Blood samples were centrifuged at 3600 g for 10 min at 48C, plasma was separated and stored at 2 808C until analysis. In all plasma samples, the following target compounds: CGA, CA, DHCA, FA, DHFA, apigenin and luteolin were analyzed in duplicate with and without enzymatic hydrolysis to detect free and conjugated form. Single phenol levels were evaluated by HPLC with electrochemical detector before and after enzymatic hydrolysis as described by Bugianesi et al. (2004) with slight modification. Briefly for free forms, 100 ml ascorbic acid solution (1 %) was added to 0·5 ml plasma and after vortexing and protein precipitation by 500 ml 3 mol/l HCl-MeOH (1:1, v/v), free phenols were extracted by adding 2 ml ethyl acetate, followed by stirring and sonication (2 -3 min) before centrifugation at 1700 g for 5 min. The extraction procedure was repeated twice and the two organic layers were combined and evaporated. The residue was dissolved into 200 ml mobile phase (phosphate buffer pH 2·8 and methanol (1:1, v/v)). Total phenols were evaluated after adding 100 ml ascorbic acid solution (1 %), 100 ml 0·2 M acetic acid and 50 ml b-glucoronidase Type HP2 from Helix Pomatia (Sigma-Aldrich Srl, Milan, Italy). After incubating at 378C for 1 h proteins were precipitated by adding 700 ml 3 mol/l HCl -MeOH (1:1, v/v), and total plasma phenols were extracted as previously described for free forms. Blank reagents were performed for free and total phenols forms evaluation. Quantitative analyses were performed on 50 ml extract using an ESA -HPLC system (ESA, Chelmsford, MA, USA). The HPLC system used consisted of an ESA MODEL 540 refrigerated autoinjector (48C), an ESA MODEL 580 solvent delivery module with two pumps, an ESA 5600 eight-channels coulometric electrode array detector and the ESA coularray operating software which controlled all the equipment and carried out data processing. A Supelcosil LC-18 column (25 cm £ 4·6 mm, 5 mm) with a Perisorb Supelguard LC-18 (Supelco, Milan, Italy) was used.
Chromatography was performed at 308C, at a flow rate of 0·8 ml/min using the following solvent system: solvent A, 0·02 mol NaH 2 PO 4 -H 2 O adjusted to pH 2·8 with 85 % orthophosphoric acid; solvent B, methanol. The linear gradient used consisted of 10 % solvent B, increasing to 30 % over 7 min and to 33 % over 28·5 min, increasing to 45 % over 19·5 min, held for 8·5 min and reaching the final condition of 100 % 24 min later, after that returning to 10 % solvent B over 3 min and maintaining this condition for 4 min. The flow rate of the eluent was constant at 0·8 ml/min and the setting potentials were 60, 120, 200, 340, 480, 620, 760 and 900 mV. Sample peaks were analyzed by matching target peaks with standard peaks on the basis of their retention time and on accuracy ratio between adjacent channels. The correlation coefficient for all calibration curves was . 0·99. Spiked samples were processed and analyzed exactly as described earlier. Mean recovery of polyphenol standards added to plasma (n 3) was .80 -118 % for CGA, DHCA, CA, DHFA and FA. The method showed a good reproducibility with coefficient of variation within days , 5 % and between days , 9 %. Limits of detection were 2·5 ng/ml for CGA, DHCA, DHFA and FA and 2·7 ng/ml for CA.
Statistics
Data are given as the mean and standard deviation. Statistical analysis was performed using the non-parametric Friedman ANOVA test and the Wilcoxon matched pairs test. Differences were considered significant at P,0·05. The computer program used was STATISTICA for Windows (release 4·5; StatSoft Inc., Vigonza PD, Italy).
Results
The composition of both raw and cooked artichoke heads is reported in Table 2 . In order to evaluate the effect of domestic cooking on the content of polyphenols, the artichoke heads were analyzed before and after cooking, observing slight increase in CGA content. In addition, after cooking, the increasing of mono-and di-caffeoylquinic acids and the appearance of cynarin were observed. There were no differences in luteolin-glycoside and apigenin-glycoside content. The evaluation of polyphenol content in raw food has been widely studied and optimized on different food matrixes (Hertog et al. 1992 Fig. 1 shows the plasma concentrations of target compounds after consumption of cooked artichoke heads. Maximum concentration of 6·4 (SD1·8) ng/ml for CGA was reached after 1 h and declined until its disappearance within 2 h (P, 0·05).
Peak plasma concentrations of 19·5 (SD 6·9) ng/ml for total CA were reached within 1 h while FA plasma concentrations showed a biphasic profile with 6·4 (SD 1·5) ng/ml and 8·4 (SD 4·6) ng/ml within 1 h and after 8 h respectively. We observed a significant (P,0·05) increase with respect to baseline for both CA and FA after administration of cooked head of artichoke during the entire experimental time. Increase of DHCA and DHFA total levels was observed within 8 h, to 12·1 (SD 7·2) ng/ml (P,0·05) and 21·8 (SD 9·2) ng/ml (P, 0·05) respectively.
Representative chromatograms in Fig. 2 show the absorption profiles in one subject of target artichoke compounds at baseline and during the entire experimental time compared to specific standards. The unnamed peaks have to be considered unknown.
No circulating plasma levels of luteolin and apigenin were present.
Discussion
The current study shows that some artichoke compounds are able to cross the gastric barrier; our findings demonstrate that artichoke target compounds, after crossing the intestinal barrier, reach biologically effective concentrations in the bloodstream. It is well known that most classes of polyphenols are sufficiently absorbed to have the potential to exert biological effects. For example, quercetin after consumption of a meal containing onions, catechins after tea consumption, isoflavones after soya consumption and caffeic acid after drinking red wine, reach micromolar concentrations in blood (Abu Amsha Caccetta et al. 1996; Hollman et al. 1997; Maiani et al. 1997; Scalbert & Williamson, 2000; Manach et al. 2002) . Bioavailability depends on several endogenous and exogenous factors; the endogenous seem to be related to food matrix, size, chemical structure and ingested amount, the exogenous to digestive enzyme activities and bile excretion, and biotransformations related to liver, kidney, gastrointestinal epithelium and gut microbial flora.
The mean time to reach maximum concentration of 6·4 (SD1·7) ng/ml for CGA is surprising. Some authors have observed a fast absorption of CGA after oral administration of pure CGA and honeysuckle flower extract in rat (Lafay et al. 2006) and rabbit (Yang et al. 2004) respectively. Unmodified CGA also appears in human urine (Cremin et al. 2001; Olthof et al. 2001; Ito et al. 2005) . On the contrary, other authors have failed to detect intact CGA in plasma after its administration as a pure compound in rats (Azuma et al. 2000) or after ingestion of coffee in human subjects (Nardini et al. 2002) . The rapid plasma detection of CGA could be due to absorption of intact CGA through the stomach or the small intestine barrier. Lafay et al. (2006) have identified unchanged CGA in both the gastric vein and aorta showing that the stomach could be involved in CGA absorption in rats. Olthof et al. (2001) have indicated that one third of ingested CGA was absorbed in the small intestine in human subjects. Nevertheless, our low plasma CGA levels suggest that the largest portion of CGA and caffeoylquinic acids have undergone biotransformations.
CGA and caffeoylquinic acid hydrolysis, and their metabolites release, could begin in the small intestine. In addition, Andreasen et al. (2001) have shown that esterases with activity similar to esters of the major dietary hydroxycinnamates are distributed throughout the intestinal tract of mammals.
The observed CA and FA plasma levels could originate from hydrolysis of both CGA and caffeoylquinic acids, that represent the predominant polyphenol forms in the test meal. Free plasma levels were low with respect to total forms of CA and FA (Wittemer et al. 2005) ; CA and FA conjugates reached the maximum concentration within 1·5 h. This result seems to suggest that the hydrolysis of active compounds of artichoke heads should have partially occurred in the small intestine (Lafay et al. 2006; Azuma et al. 2000; Nardini et al. 2002) .
On reaching the large intestine, unchanged CGA is hydrolyzed by colon enzymes into various aromatic acid metabolites before absorption (m-coumaric acid, derivatives of phenylpropionic and benzoic acids; Booth et al. 1957; Rechner et al. 2001a) . Several metabolites have been identified after ingestion of CGA or CA, namely FA, isoFA, DHFA and vanillic acid in human subjects (Rechner et al. 2001b) .
The colonic microflora has been designated as the major metabolic site for the reactions of the cleavage of ester or glycoside bonds, releasing free hydroxycinnamic acids (Plumb et al. 1999; Couteau et al. 2001; Rechner et al. 2001a) .
CA, released by gut microflora, was absorbed and transported to the liver for o-methylation to FA (Masri et al. 1964; Scheline, 1991; Gumbinger et al. 1993; Moridani et al. 2001) . Nevertheless the gut microflora could be able to catalyze the o-methylation of CA to yield FA and isoFA (Chesson et al. 1999) .
From our findings, the mean time to reach maximum concentration for DHCA and DHFA was 6-8 h (Wittemer et al. 2005) . The decrease of CA levels within 6 h and the simultaneous increase of DHCA and DHFA in the bloodstream seem to suggest that CA, released after hydrolysing CGA and caffeoylquinic acids by microflora, was metabolized into DHCA before absorption (Peppercorn & Goldman, 1971) . This result could indicate the gut as probable and predominant location of hydroxycinnamate esters metabolism (Andreasen et al. 2001 , Couteau et al. 2001 .
Absorbed DHCA could be methylated into DHFA and then dehydrogenated into FA in the liver (Moridani et al. 2001) . Nevertheless our results indicate that the same reaction mechanisms could take place in the large intestine, particularly dehydrogenation by the colon flora and methylation inside the colon wall. This may contribute to explaining the biphasic concentration profile observed in our samples for total FA. Moridani et al. (2002) have reported that CA and DHCA biotransforming reactions, such as o-methylation, GSH conjugation, hydrogenation and dehydrogenation, take places in the liver catalyzed by P450 cytocrome. On the other hand, some researchers suggest that CA and DHCA methylation into FA and DHFA respectively may occur in the gut (Booth et al. 1957; Chesson et al. 1999; Ranganathan & Ramasarma, 1974) . In both rats and human subjects, dietary plant phenolics can undergo metabolism to form reactive intermediates by catechol-o-methyltransferases present in the liver, also in the kidneys and gastrointestinal tracts both stomach and intestine (Nissinen et al. 1988; Schultz & Nissinen, 1989; Mannisto et al. 1992) . The lack of circulating levels of luteolin and apigenin could be due to their low concentrations in the test meal administered. Several factors may explain the variability of the polyphenols bioavailability, such as the food matrix or background diet. In addition inter-individual variations are also important, because some people might have different levels of metabolizing enzymes or transporters, enabling more efficient absorption of bioactive compounds.
In conclusion, our study shows for the first time the absorption pathways of hydroxycinnamic acids after consumption of edible cooked artichoke in human subjects. These results should be supported by other investigations to confirm the biological activity of cooked artichoke in human subjects and to better understand the mechanism of food phenolic metabolism. With the current conflict existing in the understanding of the metabolism of hydroxycinnamic acids further research is required.
